Results 51 to 60 of about 38,505 (164)

[Internal biliary diversions in inoperable neoplasms of the biliary tract and pancreas].

open access: yesIl Giornale di chirurgia, 1991
The authors report their experience with the treatment of mechanical jaundice in inoperable malignant neoplasms of the bile ducts and pancreas. They emphasize the importance of intrahepatic peripheral biliodigestive derivations (Soupault and Couinaud operation).
G, Giordano   +8 more
openaire   +1 more source

Significance of serum ferritin as a prognostic factor in advanced hepatobiliary cancer patients treated with Korean medicine: a retrospective cohort study

open access: yesBMC Complementary and Alternative Medicine, 2018
Background Advanced hepatobiliary cancers are highly lethal cancers that require precise prediction in clinical practice. Serum ferritin level increases in malignancy and high serum ferritin level is associated with poor survival in various cancers. This
Anna Song   +4 more
doaj   +1 more source

Intraductal papillary mucinous neoplasm of the biliary tract: A precursor lesion to cholangiocarcinoma

open access: yesRadiology Case Reports, 2019
Intraductal papillary mucinous neoplasm of the biliary tract (IPMN-B) is an increasingly recognized pathologic entity characterized by intraluminal papillary masses and increased mucin secretion, resulting in obstruction and dilation of the biliary tree.
David J. Ritchie, MD   +2 more
openaire   +3 more sources

FOLFIRI as second-line treatment of metastatic biliary tract cancer patients

open access: yesAutopsy and Case Reports, 2019
The combination of cisplatin and gemcitabine is the standard first-line treatment of metastatic biliary tract cancer (BTC) patients. The benefit of second-line chemotherapy in these patients is controversial.
Rafael Caparica   +3 more
doaj  

Durvalumab plus gemcitabine-cisplatin versus S-1 plus gemcitabine-cisplatin in advanced biliary tract cancer: a comparative study

open access: yesESMO Gastrointestinal Oncology
Background and purpose: Following the TOPAZ-1 trial, chemoimmunotherapy with durvalumab plus gemcitabine and cisplatin (GCD) became the standard first-line treatment of advanced biliary tract cancer (BTC).
T. Satake   +10 more
doaj   +1 more source

Multiple metallic stents placement for malignant hilar biliary obstruction: Perspective of a radiologist

open access: yesGastrointestinal Intervention, 2016
In the palliative setting, the necessity of biliary drainage of both liver lobes for malignant hilar biliary obstruction remains controversial. However, bilateral biliary drainage is a reasonable option to prevent cholangitis of the undrained lobe and to
Yozo Sato   +6 more
doaj   +1 more source

Incidental diagnosis of intraductal papillary neoplasm of the bile duct: Imaging findings from a case report

open access: yesRadiology Case Reports
Intraductal papillary neoplasms of the bile ducts (IPNBs) represent a rare biliary tract tumors with malignant potential, requiring surgical resection to prevent progression to cholangiocarcinoma.
Imene Chafai, MD   +2 more
doaj   +1 more source

Aspirin use is associated with a reduced risk of cholangiocarcinoma: a systematic review and meta-analysis

open access: yesCancer Management and Research, 2018
Jianping Xiong,* Weiyu Xu,* Jin Bian, Hanchun Huang, Yi Bai, Yiyao Xu, Xin Lu, Haitao Zhao Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing,
Xiong JP   +7 more
doaj  

Poorly Cohesive Carcinoma of Common Bile Duct: A Rare Histological Type of Cholangiocarcinoma

open access: yesClinical Medicine Insights: Case Reports
Biliary tract carcinomas (BTC) are malignant epithelial neoplasms subdivided anatomically into: gallbladder carcinomas and carcinomas of the bile duct or cholangiocarcinomas (CCA); including intrahepatic, hilar/perihilar, and distal CCA.
Derqaoui Sabrine   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy